Author

Alexander Locke

Observed name: Alex Locke

Institution: California Northstate University

Observed institutions: United States Department of Health and Human Services, National Institutes of Health, Kaiser Permanente, Kaiser Permanente Oakland Medical Center, Kaiser Permanente South Sacramento Medical Center, Kaiser Permanente Sacramento Medical Center, National Cancer Institute, California Northstate University, Division of Cancer Epidemiology and Genetics, Kaiser Permanente Northern California

ORCID: 0000-0002-2822-4669

Observed ORCID: 0000-0002-2822-4669

OpenAlex ID: A5060618328

Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines

2020 · Didem Egemen, Li C. Cheung, et al. · Journal of Lower Genital Tract Disease · 279

Accuracy and Efficiency of Deep-Learning–Based Automation of Dual Stain Cytology in Cervical Cancer Screening

2020 · Nicolas Wentzensen, Bernd Lahrmann, et al. · JNCI Journal of the National Cancer Institute · 186

Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program

2019 · Nicolas Wentzensen, Megan A. Clarke, et al. · JAMA Internal Medicine · 183

Recommendations for Use of p16/Ki67 Dual Stain for Management of Individuals Testing Positive for Human Papillomavirus

2024 · Megan A. Clarke, Nicolas Wentzensen, et al. · Journal of Lower Genital Tract Disease · 83

Clinical Outcomes after Conservative Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) in Women Ages 21–39 Years

2018 · Michelle I. Silver, Julia C. Gage, et al. · Cancer Prevention Research · 47

Primary human papillomavirus testing vs cotesting: clinical outcomes in populations with different disease prevalence

2024 · Shrutikona Das, Nicolas Wentzensen, et al. · JNCI Journal of the National Cancer Institute · 11

The relationship of human papillomavirus and cytology co-testing results with endometrial and ovarian cancer diagnoses

2021 · Philip E. Castle, Alexander Locke, et al. · Gynecologic Oncology · 5

Calendar-period trends in cervical precancer and cancer diagnoses since the introduction of human papillomavirus and cytology co-testing into routine cervical cancer screening at Kaiser Permanente Northern California

2024 · Brian Befano, Nicolas Wentzensen, et al. · Gynecologic Oncology · 2

Invasive Cervical Cancer After a Positive Pap Test Result and Negative Human Papillomavirus Test Result

2021 · Alexander Locke, Nina R. Shah, et al. · Obstetrics and Gynecology · 2

Beyond Estrogen: Distribution and Hormonal Correlates of Serum Testosterone Among Postmenopausal U.S. Women, NHANES 2011–2016 and 2021–2023

2026 · Andrew J. Goulian, Isaac Wilson, et al. · Journal of Clinical Medicine

Data from Clinical Outcomes after Conservative Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) in Women Ages 21–39 Years

2023 · Michelle I. Silver, Julia C. Gage, et al.

Supplementary Tables 1 and 2 from Clinical Outcomes after Conservative Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) in Women Ages 21–39 Years

2023 · Michelle I. Silver, Julia C. Gage, et al.

Data from Clinical Outcomes after Conservative Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) in Women Ages 21–39 Years

2023 · Michelle I. Silver, Julia C. Gage, et al.

Works count: 13

Citation count: 797

H-index: 6

I10-index: 6